Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Fusion Lumos
ORGANISM(S): Mus Musculus (mouse)
TISSUE(S): Retina
SUBMITTER: Zhongjie Fu
LAB HEAD: Zhongjie fu
PROVIDER: PXD052730 | Pride | 2025-05-07
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
41_HY_P17H.mzML | Mzml | |||
41_HY_P17H.mzid.gz | Mzid | |||
41_HY_P17H.pdResult | Other | |||
41_HY_P17H.zip | Other | |||
41_HY_P17H_Dexa_1.raw | Raw |
Items per page: 5 1 - 5 of 17 |
Yagi Hitomi H Boeck Myriam M Petrishka-Lozenska Mariya M Lundgren Pia P Kasai Taku T Cagnone Gael G Neilsen Katherine K Wang Chaomei C Lee Jeff J Tomita Yohei Y Singh Sasha A SA Joyal Jean-Sébastien JS Aikawa Masanori M Negishi Kazuno K Fu Zhongjie Z Hellström Ann A Smith Lois E H LEH
Angiogenesis 20240917 4
Pathological neovascularization in retinopathy of prematurity (ROP) can cause visual impairment in preterm infants. Current ROP treatments which are not preventative and only address late neovascular ROP, are costly and can lead to severe complications. We showed that topical 0.1% dexamethasone eye drops administered prior to peak neovessel formation prevented neovascularization in five extremely preterm infants at high risk for ROP and suppressed neovascularization by 30% in mouse oxygen-induce ...[more]